Delivery Order SPE2DB22D1041-SPE2DB24FTZZ1

Award Date 2/27/24
Potential Completion Date 2/28/24
Potential Value $17K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $7,428.83, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $13,348.98, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is a delivery order, with a firm fixed price pricing type, and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $22,735.31, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price, and the ultimate completion date is January 19, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,379.45 and is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC has a total potential value of up to...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $11,552.33, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 6, 2022. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This...
This federal contract award is for the delivery of Eliquis 5 mg tablet medication to the Defense Logistics Agency (DLA). The $13,060.89 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $13,271.92, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive...
This federal contract award is for the delivery of Eliquis 5mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $16,457.61, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 2, 2023 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,710.77, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which does business as Amerisourcebergen. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB24FTZZ1
    Delivery Order

This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $16,650.77, is a Firm Fixed Price Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 5/14/25, 10:00 AM